CompletedNot Applicable

Balloon Pump Assisted Coronary Intervention Study

United Kingdom301 participantsStarted 2005-12

Plain-language summary

This study will test the hypothesis that elective use of the Intra-Aortic Balloon Pump (IABP) in patients undergoing high-risk Percutaneous Coronary Intervention (PCI) will reduce the rate of in-hospital major adverse cardiac and cerebrovascular events compared to patients who are managed without planned insertion of IABP.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * impaired left ventricular function (Ejection Fraction \< 30%) * large area of myocardium at risk (BCIS-1 Myocardial Jeopardy Score ≥ 8/12) Exclusion Criteria: * cardiogenic shock * acute STEMI within previous 48 hours * complications of recent AMI (including ventricular septal defect, severe mitral regurgitation, intractable ventricular arrhythmias) * contraindications to IABP use (including significant iliac or femoral arterial disease and more than mild aortic regurgitation)

What they're measuring

Major Adverse Cardiac and Cerebrovascular Events

Timeframe: Hospital discharge or 28 days following PCI, whichever occurs sooner

Trial details

NCT IDNCT00910481

SponsorBritish Cardiovascular Intervention Society

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-01

Results submitted2021-02-06

View on ClinicalTrials.gov More Coronary Artery Disease trials